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The relationship between mast cells (MCs) and pregnancy is a controversially discussed
topic. The presence and quantitative distribution of MCs in the reproductive tract was
conﬁrmed in different species. A phase-dependent oscillation of MCs during the hormonal
regulated estrous cycle was suggested and on this basis, MCs were assumed to play a
positive role in implantation because of their ability to secrete histamine. At later pregnancy
stages, they were proposed to have rather a negative role, as their exacerbated activation
is associated with pre-term delivery.The present review is intended to provide an overview
about uterineMCs that bring to light their unexpected relevance for reproductive processes.
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INTRODUCTION
Already in the early 60s and 70s the presence and quantitative dis-
tribution of mast cells (MCs) in the reproductive tract in general
and during the estrous cycle in particular was described in differ-
ent species like rat (Gibbons and Chang, 1972), hamster (Harvey,
1964), and cow (Likar and Likar, 1964). The phase-dependent
oscillation of MC numbers during the hormone-regulated estrous
cycle was described and assumed that they are important for
implantation because they secrete substances that promote tissue
remodeling necessary for this process. The functional importance
of these data was however unclear as the results were based on the
methodological simplicity at that time. Later on, a role for MCs
in reproduction was dismissed because of the apparently normal
pregnancy outcome of mice lacking MCs. We have recently inves-
tigated the importance of MC deﬁciency in pregnancy outcome
using a mouse model. The present review is intended to provide
an overview about the available as well as novel data from us and
many others, that bring to light the unexpected relevance of MCs
for reproductive processes.
UTERINE MCs REPRESENT A DIVERGENT PHENOTYPE FROM
OTHER DESCRIBED MCs
Based on their tissue speciﬁcity, murine MCs are typically classi-
ﬁed as either mucosal or connective tissue-type MCs (Metcalfe
et al., 1997). Thereby, this classiﬁcation is attributed, i.a. to
their histochemical staining patterns especially to those of the
granule-stored proteases. Already in 1960, Spicer suggested that
uterine MCs (uMCs) represent a divergent phenotype composed
of mucosal as well as connective tissue-type MCs (Spicer, 1960).
The histochemical observations were done by using a combined
Alcian blue–Safranin stain whereby mucosal MCs are Alcian blue-
positive and Safranin-negative and connective tissue-type MCs
are Alcian blue-negative and Safranin-positive, respectively. In
our laboratory we could conﬁrm Spicer’s ﬁndings on the presence
of both MC types. uMCs were positive either for Alcian blue or
for safranin. In addition, we found a third MC population that
was positive for both dyes (Woidacki et al., 2013). These cells were
alreadydescribed and reportedly reﬂect different stages of differen-
tiation (Reynolds et al., 1988; Kitamura, 1989). Moreover, they can
derive from or represent an ongoing transdifferentiation process,
during which mature MCs may change their content in proteo-
glycans, amines, peptides, etc. (Michaloudi and Papadopoulos,
1999). These conversion processes might be induced as a response
to local inﬂammatory processes (Kitamura, 1989; Tsuji et al., 1990;
van Overveld, 1990; Moon et al., 2010) or the presence of ﬁbrob-
lasts (Levi-Schaffer et al., 1986). Here, the most important growth
factor forMCs, stem cell factor (SCF), could serve as a pivotal stim-
ulus. It was described that MC proliferation and differentiation in
the uterus is regulated by SCF secretion from uterine smooth mus-
cle cells (Mori et al., 1997b). Furthermore, it is known that heparin
is essential by controlling the levels of speciﬁc granule proteases
inside MCs (Humphries et al., 1999). Thereby, the tissue-speciﬁc
MC phenotype can vary in different mouse strains. In BALB/c,
ear MCs express MC protease 7 (Mcpt-7), the analog of human
tryptase α/β 1. In contrast, ear MCs from C57BL/6J contain no
detectable protein levels of Mcpt-7 (Ghildyal et al., 1994). During
pregnancy, uMCs seem to maintain their heterogeneity as in the
pregnant human uterus tryptase-positive and chymase-negative
(MCT) as well as tryptase-positive and chymase-positive (MCTC)
MCs are present (Garﬁeld et al., 2006). In pregnant rats, uMCs
have been identiﬁed likewise as mucosal and connective tissue-
type MCs based on their speciﬁc protease content (Salamonsen
et al., 1996). It is therefore clear that uMCs represent a heteroge-
neous population of cells and they can change their phenotype
according to local stimuli. Thus, uMCs constitute a special pop-
ulation with unique characteristics and a high plasticity, which
is important to consider when designing experiments to analyze
their role in utero.
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uMCs OSCILLATE DURING THE ESTROUS CYCLE
The presence of uMCs and their menstrual or estrous cycle-related
variations in number and structure were described in humans
(Drudy et al., 1991a,b; Mori et al., 1997a) and other mammals
like mouse (Padilla et al., 1990), rat (Aydin et al., 1998), hamster
(Harvey, 1964), and goat (Karaca et al., 2008). In mouse, uMCs
seem to reach their highest level during the receptive phase of
the female, namely in estrus (Woidacki et al., 2013), when the
uterus is prepared for nidation. This is in line with results in rats
reported by Aydin et al. (1998). They detected the highest num-
ber of MCs in estrus as well. If fecundation did not occur the
MC number in metestrus was decreased. After pregnancy estab-
lishment, uMC numbers became even higher (Woidacki et al.,
2013). This might be due to the interplay of the sexual hormones
17β-estradiol and progesterone. In mice, maximum 17β-estradiol
levels were observed at estrus whereas progesterone levels were
lowest at this phase (Fata et al., 2001). Estradiol is known to poten-
tiate the degranulation of MCs in vitro (Cocchiara et al., 1992). All
these observations indicate a hormone-dependent regulation of
uMCs. This is further reinforced by our recent observations. We
found that not only MCs express the receptors for estrogens and
progesterone but these hormones in combination can attract MCs
in vitro and in vivo to uterine cells (Jensen et al., 2010).
MAST CELLS ARE IMPORTANT FOR INDUCTION AND
MAINTENANCE OF PREGNANCY
The fundament of a successful pregnancy outcome in mammals is
the maternal tolerance of the semi-allogenic fetus based on a well-
orchestrated modulation of the maternal immune system and the
functionality of the hormonal system. A variety of innate and
adaptive immune cells are participating in this concert especially
locally at the feto-maternal interface including uterine natural
killer cells (Greenwood et al., 2000; Bilinski et al., 2008), den-
dritic cells (Blois et al., 2004; Plaks et al., 2008), and regulatory
T cells (Aluvihare et al., 2004; Zenclussen et al., 2006; Schumacher,
2013), whereas the function of MCs inmaternal tolerance is uncer-
tain. High amounts of MCs were detected in the uterus during
pregnancy (Menzies et al., 2012) and MC density was signiﬁcantly
higher in tissue frompregnant women than those of non-pregnant
women (Garﬁeld et al., 2006). We conﬁrmed high numbers of
uMCs in early pregnancy stages in a mouse model. uMCs were
mainly distributed between implantation sites. Implantations
from MC-deﬁcient C57BL/6J-KitW−sh/W−sh (W-sh), whose MC
deﬁciency is caused by a defective c-Kit signaling, showed a delayed
kinetic of development with a signiﬁcantly diminished size in
comparison to wild-type, MC sufﬁcient controls (Woidacki et al.,
2013). The transfer of bone marrow-derived MCs (BMMCs) into
W-sh mice positively inﬂuenced the size of the implantation sites
and restored them to normal levels (Woidacki et al., 2013). It is
important to remark that a delayed implantationmight have a fatal
impact in pregnancy outcome (Song et al., 2002). This is further
evidenced by our ﬁndings on insufﬁcient placentation and remod-
eling of spiral arteries in W-sh mice (Woidacki et al., 2013). The
embryo itself could act as the stimulus for the implantation pro-
cess. Here, the embryo-derived histamine-releasing factor (EHRF)
might be one of the ﬁrst signals from the embryo to the uterus. The
EHRF-induced local secretion of histamine by uMCs could play a
role in preventing maternal immune rejection at the implantation
stage (Cocchiara et al., 1986).
Some studies are based on histamine as an important MC-
speciﬁc mediator for the initiation of blastocyst implantation
processes and decidual cell responses (Shelesnyak, 1957, 1959;
Nalbandov, 1971). However, the increment of the uterine his-
tamine levels in MC-deﬁcient WBB6F1-W/WV (W/WV) after
steroid treatment (Wordinger et al., 1985) suggests an alternative
source of histamine like endothelial cells (Robinson-White et al.,
1982) or/and decidual cells which have been shown to release
histamine upon stimulation (Schrey et al., 1995). A study from
Wordinger et al. (1986) makes the discussion even more contro-
versial. The sterility of MC-deﬁcient WBB6F-W/WV is mainly
due to atrophic ovaries with a hyperplastic stroma and absence
of follicles and distinct corpora lutea (Wordinger et al., 1985). To
determine whether implantation and live births occurred in the
absence of uMCs, Wordinger et al. (1985) employed a model of
ovariectomized female W/WVmice. After the transplantation of
one ovary obtained from normal female littermates (+/+) the
authors transferred blastocysts from +/+ into pseudopregnant
W/WV. They could not ﬁnd any differences between W/WV and
+/+ in the implantation rate after blastocyst transfer or in the
number of live births. Because of these observations, Wordinger
et al. (1985) excluded any requirement of uMCs in these processes.
However, the transplanted ovaries were obtained from +/+ and
should therefore contain a remarkable amount of already mature
and differentiatedMCs that could thenmigrate to the surrounding
tissue and expand. We recently observed that locally transferred
MCs into one single uterine horn were located in the other,
untreated, uterine horn shortly thereafter (Woidacki et al., 2013).
In the Wordinger study, no information is available regarding
the presence of MCs in the ovary before and after transplanta-
tion. Additionally, the recipients were treated with steroids and
MCs are known for their susceptibility to the action of hormones
like estradiol and progesterone (Wordinger et al., 1985; Cocchiara
et al., 1992; Rudolph et al., 2004; Jensen et al., 2010) which proba-
bly induced the expansion of the MCs present in the ovaries and
their migration to the uterus. We detected high amounts of MCs
within the ovaries (unpublished observations) that coincides with
observations done in different species like mouse (Skalko et al.,
1968), rat (Jones et al., 1980; Gaytan et al., 1991; Aydin et al., 1998;
Batth and Parshad, 2000), hamster (Shinohara et al., 1987; Krishna
and Terranova, 1991), cow (Reibiger and Spanel-Borowski, 2000),
goat (Karaca and Sims¸ek, 2007; Karaca et al., 2008), and chicken
(Parshad and Kathpalia, 1993). Furthermore, we could not ﬁnd
alterations in the number of follicles as well as corpora lutea
between MC-deﬁcient W-sh and control mice (Woidacki et al.,
2013). As early pregnancy is highly dependent on the presence
of corpora lutea and the progesterone they secrete, we conclude
that the establishment of pregnancy does not seem to depend
on MCs but implantation and embryo development surely does
(Woidacki et al., 2013).
On day 10 of murine normal pregnancies, MCs were present
in the decidua, the maternal part of the feto-maternal inter-
face and located closed to blood vessels (Woidacki et al., 2013).
In pregnant rats, the degranulation of MCs positively inﬂu-
enced angiogenesis (Varayoud et al., 2004; Bosquiazzo et al., 2007).
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Nevertheless, some studies exclude MCs as important media-
tors of pregnancy-relevant processes. Salamonsen et al. (1996)
applied to syngeneically mated female rats a highly potent MC
stabilizer (FPL 55618). They claimed no differences in the num-
ber of implantation sites. This is remarkable, but taking a closer
look at the data, as e.g., two of a total of ﬁve rats receiving
FPL intraperitoneally failed to show any embryo implantation
(Salamonsen et al., 1996), meaning only 60% of the animals,
got pregnant compared to more than 80% in the control group.
Furthermore, the low number of animals employed it is question-
able to make such strong conclusions based only in a subgroup
of the studied group. Menzies et al. (2012) recently suggested
that the absence of MCs had no discernible impact on preg-
nancy. In this study, MC-deﬁcient C57BL/6J-KitW−sh/W−sh and
their wild-type counterparts, both syngeneically mated, had sim-
ilar offspring birth weights and no difference in fetal–placental
index. However, neither the kinetic nor the occurrence of implan-
tations was analyzed or reported by these authors. That survivor
animals develop normally does not discard that the ﬁrst stages
of pregnancy are dependent on MCs. Despite that, this study
concentrated on those pregnancies that succeed after implan-
tation and no data is provided as to how many females were
pregnant after plug detection and how many blastocysts could
be implanted, these authors concentrated on syngeneic matings.
These two publications denying a role of MCs in pregnancy
share one aspect: they are based on syngeneic and therefore bio-
logically questionable matings. Naturally occurring pregnancies
in natura are predominantly allogeneic to maintain the genet-
ical variability of a species. That allows the adaptation of the
fetus to its later environment at the best. Matings with genet-
ically related and even worse among identic individuals has to
be avoided because of the partially tremendous consequences of
inbreeding. Syngeneic matings are exclusively necessary to main-
tain inbreeding colonies in the laboratories. Even there, after some
generations mostly a backcross to wild-types has to be done as a
result of the genetic impoverishment. Madeja et al. (2011) could
show that murine allogeneic fetuses and placentas were heav-
ier at term compared with syngeneic controls. This consequence
was based on impaired decidual vascularization as well as pla-
cental and fetal growth after syngeneic matings. They supposed
that allogeneic placentas are much more sufﬁcient in supporting
fetal growth by adequate modulation of spiral arteries. It seems
reasonable to assume that paternal allo-antigens are important
for stimulating maternal immune cells, which is not further dis-
cussed as it would go beyond the scope of this article. In this
context, the role of MCs is worth to be studied and critically
analyzed in efﬁcient, relevant allogeneic pairings as the results
obtained in syngeneic ones are limited by the already mentioned
factors.
MC-deﬁcient C57BL/6J-KitW−sh/W−sh (W-sh) mice implanted
signiﬁcantly less blastocysts than theirwild-type counterparts after
allogeneic mating. Uteri from W-sh mice were either very thick,
swollen, and reddish with no visible implantations or contained
few implantations. Accordingly, their litter size was signiﬁcantly
reduced as compared to wild-type controls. The systemic and
local reconstitution with BMMC completely restored the repro-
ductive phenotype of W-sh mice. Moreover, the few implanted
blastocysts in W-sh mice developed signiﬁcantly smaller placentas
and insufﬁcientmodiﬁcations of the spiral arteries that are respon-
sible for supplying oxygen and nutrients to the fetus. BMMC
transfer normalized all parameters and therefore contributed to a
normal pregnancy outcome by mediating placental development
and spiral artery remodeling (Woidacki et al., 2013).
Inadequate placental development mainly due to discrepan-
cies in trophoblast differentiation and invasion, respectively can
lead to intrauterine growth retardation (IUGR) and pre-eclampsia
amongst other complications. In placentas obtained from IUGR-
pregnancies the number of MCs was markedly decreased while
hypoxia could intensify MC degranulation (Szukiewicz et al.,
1999b). The degranulation of MCs resulted in a greater increase
of the vascular resistance in pre-eclampsia likely due to the vaso-
constrictive function of histamine (Szukiewicz et al., 1999a) and
asthmatic pregnant women are at increased risk to develop this
disease (Siddiqui et al., 2008; Murphy et al., 2011). In severe
pre-eclampsia, the number of human MC chymase-positive cells
was signiﬁcantly higher compared to normal pregnant women
(Mitani et al., 2002) and MC-chymase is known to be more potent
than angiotensin-converting enzyme to convert angiotensin I to
angiotensin II (Wintroub et al., 1984). Whether the secreted his-
tamine, that inhibits the apoptotic activity in trophoblast cells
via H(1) receptor (Pyzlak et al., 2010) and further inﬂuences the
process of trophoblast differentiation (Szewczyk et al., 2005) and
invasion (Liu et al., 2004) is derived exclusively from MCs has to be
still determined. Thus, the heterogenicity of uMCs is also depicted
here: low numbers of uMCs is associated with pathologies as
IUGR which would predict a positive role of uMCs on fetal growth
while their exacerbated activation is related to pre-eclampsia and
pre-term birth. Hence, uMCs represent a heterogenous popula-
tion, which shows also a high plasticity to respond differently to
different stimuli.
MCs AND THEIR INFLUENCE ON PERINATAL PROCESSES
There are strong hints for the relevance of MCs in mediating
the implantation of the blastocyst as discussed above. As preg-
nancy advances, MCs exert an inﬂuence on the maintenance of
pregnancy by allowing the unrestricted development of the pla-
centa and remodeling of the spiral arteries (Woidacki et al., 2013).
Interestingly, there are vast evidences that MCs also inﬂuence
perinatal processes. The degranulation of MCs can lead to sub-
stantial changes in the myometrial contractility (Martínez et al.,
1999; Garﬁeld et al., 2006). Resident MCs increased uterine con-
tractility in pregnant guinea pigs through multiple mediators
including histamine and serotonin. Uterine responses to these
mediators are dependent on gestational age (Bytautiene et al.,
2008). Pregnant women affected by systemic mastocytosis exhibit
manifestations of pre-term labor and delivery. This disease is
accompanied by an unexplained and pathologic increase in MCs
in speciﬁc tissue (Metcalfe andAkin, 2001). The allergic activation
of MCs results in a substantial increase in uterine contractil-
ity (Garﬁeld et al., 2006) and could be therefore responsible for
the allergy-associated induction of pre-term labor (Habek et al.,
2000; Bytautiene et al., 2004). This is in line with the fact that
pregnant women with asthma are at a higher risk to pre-term
delivery (Perlow et al., 1992; Sorensen et al., 2003; Murphy et al.,
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FIGURE 1 | Hypothetical scenario of MC-impact on pregnancy-related
processes: undifferentiated MC-precursors migrate from the periphery
into the uterus due to the simultaneous influence of estradiol and
progesterone.Their local maturation and differentiation occurs through SCF.
Amongst other mediators estradiol and progesterone could bind locally on
uMCs that further lead to their activation. The MC-activation results in a
simultaneous release of pre-formed and/or de novo synthesized mediators
including different tryptases and chymases as well as transforming growth
factor-β (TGF-β) and histamine. These mediators could directly or indirectly
affect important processes like blastocyst’s implantation, decidualization,
placentation, spiral artery remodeling, and later on labor. Trophoblast-derived
and/or peripheral TGF-β binds onTGF-β-receptors expressed on the mast cell
surface that would be a possible further mechanism for their activation. TGF-β
likewise stimulates the recruitment of other MCs from the periphery into the
fetal–maternal interface. Here, lymph nodes and spleen could serve as a
MC-reservoir in the periphery. Fibroblast- and later on trophoblast-derived
connective tissue growth factor (CtGF) is involved in matrix degradation,
angiogenesis as well as tissue remodeling.
2006). However,Menzies et al. (2012) concluded thatMCshaveno
impact on initiation of labor because the time of labor initiation in
MC-deﬁcient mice was indistinguishable from wild-type controls.
Nevertheless, the number of MCswithin themouse cervix doubled
from non-pregnant to day 18 of pregnancy, with a further 1.5-fold
increase with labor (Menzies et al., 2012). This relevant question
is worth to be tested in a mouse model for pre-term delivery and
remains highly up-to-date.
In summary our data as well as data from the literature show
that MCs accompany and deeply affect many steps of reproduc-
tion. MCs are modiﬁed and attracted by hormones, uMCs are
essential for allowing implantation of allogeneic embryos, and
positively inﬂuence placentation and thus, embryo development.
Later on, an exacerbated number or function of uMCs can nega-
tively inﬂuence pregnancy and foster pre-term delivery. It is clear
that uMCs are not only different from other MCs because of their
unique markers but also seem to secrete different mediators at
different pregnancy stages and upon different stimuli. This makes
these cells an extremely interesting target of study for both, repro-
ductive biologists andMC researchers. Based on the data discussed
in this review, we propose following hypothetical scenario for the
impact of MCs on pregnancy-related processes.
CONCLUSION
Mast cells vitally inﬂuence reproductive processes and in particular
the pregnancy itself by modulating non-immunological responses
like tissue remodeling, angiogenesis, optimal placentation, and
spiral artery modiﬁcations as well as labor. They further play a
rather negative role in parturition as the excessive secretion of
MC-mediators may lead to pre-term delivery. MCs may act not
only as mediators of the innate immune system but also as cellular
switch points between innate and adaptive immune responses.
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Their activity is regulated by endocrine and physiological sig-
nals and based on their granule-stored array of biologically active
products. All these well-orchestrated mechanisms allow the non-
restrictive development of the semi-allogeneic fetus within the
maternal uterus and therefore fetal survival. The understanding
of the paradoxon “pregnancy” is of fundamental importance for
helping couples to realize their often unfulﬁlled desire to have chil-
dren. In this context, the data in regard to the mast cell-associated
positive pregnancy outcome might serve as a further puzzle piece
to answer these questions.
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